Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer - No Study Results Posted

Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (LUTRAERL)

This study is currently recruiting participants.

Study NCT00473083 Information provided by British Columbia Cancer Agency

First Received: May 10, 2007 Last Updated: November 3, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given